CRISPR and MaxCyte In Cell Engineering Pact (CRSP) – Investopedia
Investopedia |
CRISPR and MaxCyte In Cell Engineering Pact (CRSP)
Investopedia and Casebia Therapeutics Inc. are partnering with privately-held MaxCyte Inc. for the non-exclusive commercial rights to MaxCyte's cell engineering platform to develop CRISPR/Cas9-based therapies. (See also, The Gene-Editing Revolution: What Is … |
